Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FCHSD2 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
mRNA | SH2B2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | CYYR1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | ATP6V0D1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | PPP1R15B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | TSSK3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | FAM189A1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | POU2F2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | CASP4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | NFATC2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |